Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Cenra Inc.

Market Cap 5.06B 160M 140M 129M 121M 227M 15.12B 228M 1.54B 598M 7.43B 601M 588M 25.82B P/E 2024
15.1x
P/E 2025 14x
Enterprise Value 7.32B 231M 202M 187M 174M 328M 21.86B 330M 2.22B 864M 10.75B 868M 849M 37.33B EV / Sales 2024
0.9x
EV / Sales 2025 0.83x
Free-Float
61.28%
Yield 2024
2.72%
Yield 2025 2.99%
Manager TitleAgeSince
Chief Executive Officer - 2020-11-04
Director of Finance/CFO - 2014-03-06
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member - 2016-05-26
Director/Board Member - 2021-05-20
Chairman - 2020-11-04
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%+0.71% - - 160M
+1.34%+3.05%+11.88%+87.81% 46.74B
+0.90%+4.02%+51.42%+90.96% 34.33B
+4.73%+1.89%-5.60%+40.32% 11.57B
+1.37%-1.74%+13.42%+93.80% 11.42B
-0.95%+0.96%+37.43%+127.27% 9.09B
+1.11%-2.15%+16.27%+41.36% 6.98B
-0.98%+0.83%+33.92%+240.86% 6.62B
+4.29%+6.01%+50.84%-15.23% 6.55B
+1.32%-1.66%-34.40%-0.52% 5B
Average +1.29%+0.00%+19.46%+78.52% 15.37B
Weighted average by Cap. +1.38%+0.94%+23.49%+84.61%

Financials

2024 2025
Net sales 8.92B 282M 246M 228M 213M 399M 26.63B 402M 2.71B 1.05B 13.09B 1.06B 1.03B 45.48B 8.57B 271M 237M 219M 204M 383M 25.59B 386M 2.6B 1.01B 12.58B 1.02B 994M 43.7B
Net income 317M 10.03M 8.76M 8.1M 7.56M 14.2M 947M 14.3M 96.3M 37.47M 466M 37.64M 36.83M 1.62B 300M 9.48M 8.28M 7.66M 7.15M 13.43M 896M 13.52M 91.05M 35.43M 440M 35.59M 34.82M 1.53B
Net Debt 2.46B 77.63M 67.83M 62.74M 58.56M 110M 7.34B 111M 746M 290M 3.61B 291M 285M 12.53B 2.26B 71.29M 62.29M 57.62M 53.78M 101M 6.74B 102M 685M 266M 3.31B 268M 262M 11.51B
Logo Cenra Inc.
Cenra Inc is a Taiwan-based company mainly engaged in the provision of general investment related businesses. Through its subsidiary, the Company conducts the development, manufacturing and sales of pharmaceuticals, agricultural and livestock drugs, personal hygiene and health products, as well as the import and sale of medical instruments. Its subsidiaries’ products are pharmaceuticals and health products, including human medicines, such as prescription and indicated drugs, over-the-counter medicines, and disease treatment products; medical equipment, such as blood pressure monitors, blood glucose meters, and artificial joints; animal medicines, supplementary feeds, and feed additives, providing animal treatment, disease prevention, and nutritional supplement products; daily necessities, such as toothpaste, tooth powder, mouthwash and other oral hygiene and health products, hand cleansers, dry hand sanitizers, shower gels, medicated soaps and lotion products, and skin care series.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!